AXDX
Income statement / Annual
Last year (2023), Accelerate Diagnostics, Inc.'s total revenue was $12.06 M,
a decrease of 5.43% from the previous year.
In 2023, Accelerate Diagnostics, Inc.'s net income was -$61.62 M.
See Accelerate Diagnostics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$12.06 M
|
$12.75 M
|
$11.78 M
|
$11.17 M
|
$9.30 M
|
$5.67 M
|
$4.18 M
|
$246,000.00
|
$147,000.00
|
$122,000.00
|
| Cost of Revenue |
$9.51 M |
$9.45 M |
$12.16 M |
$6.71 M |
$4.90 M |
$3.19 M |
$1.00 M |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$2.55 M |
$3.30 M |
-$381,000.00 |
$4.46 M |
$4.40 M |
$2.48 M |
$3.18 M |
$246,000.00 |
$147,000.00 |
$122,000.00 |
| Gross Profit Ratio |
0.21 |
0.26 |
-0.03 |
0.4 |
0.47 |
0.44 |
0.76 |
1 |
1 |
1 |
| Research and Development
Expenses |
$25.35 M
|
$26.92 M
|
$21.94 M
|
$21.26 M
|
$25.35 M
|
$27.64 M
|
$22.30 M
|
$28.20 M
|
$26.02 M
|
$20.05 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$31.23 M
|
$39.19 M
|
$49.24 M
|
$46.90 M
|
$51.89 M
|
$55.21 M
|
$45.06 M
|
$36.20 M
|
$17.88 M
|
$10.70 M
|
| Other Expenses |
$0.00 |
-$227,000.00 |
-$20,000.00 |
-$60,000.00 |
-$14,000.00 |
-$28,000.00 |
-$184,000.00 |
$2.35 M |
$1.79 M |
$888,000.00 |
| Operating Expenses |
$56.58 M |
$66.11 M |
$71.18 M |
$68.16 M |
$77.23 M |
$82.85 M |
$67.36 M |
$66.75 M |
$45.70 M |
$31.64 M |
| Cost And Expenses |
$66.09 M |
$75.56 M |
$83.34 M |
$74.87 M |
$82.13 M |
$86.04 M |
$68.36 M |
$66.75 M |
$45.70 M |
$31.64 M |
| Interest Income |
$1.12 M |
$551,000.00 |
$88,000.00 |
$855,000.00 |
$2.81 M |
$2.85 M |
$908,000.00 |
$494,000.00 |
$74,000.00 |
$64,000.00 |
| Interest Expense |
$7.74 M |
$3.77 M |
$15.55 M |
$15.55 M |
$14.26 M |
$10.11 M |
$0.00 |
$23,000.00 |
$23,000.00 |
$7,000.00 |
| Depreciation &
Amortization |
$3.25 M
|
$3.00 M
|
$2.52 M
|
$3.00 M
|
$2.60 M
|
$2.56 M
|
$2.20 M
|
$2.35 M
|
$1.79 M
|
$888,000.00
|
| EBITDA |
-$49.77 M
|
-$55.80 M
|
-$59.59 M
|
-$59.66 M
|
-$67.56 M
|
-$75.44 M
|
-$61.34 M
|
-$64.15 M
|
-$43.68 M
|
-$30.10 M
|
| EBITDA Ratio |
-4.13 |
-4.66 |
-5.85 |
-5.37 |
-7.25 |
-13.23 |
-15.35 |
-258.76 |
-297.16 |
-250.51 |
| Operating Income Ratio
|
-4.48
|
-4.93
|
-6.07
|
-5.71
|
-7.83
|
-14.17
|
-15.37
|
-270.33
|
-309.86
|
-258.34
|
| Total Other
Income/Expenses Net |
-$6.74 M
|
$235,000.00
|
-$6.10 M
|
-$14.50 M
|
-$11.59 M
|
-$7.75 M
|
$649,000.00
|
$394,000.00
|
$51,000.00
|
-$470,000.00
|
| Income Before Tax |
-$60.77 M |
-$62.57 M |
-$77.66 M |
-$78.20 M |
-$84.42 M |
-$88.12 M |
-$63.53 M |
-$66.11 M |
-$45.50 M |
-$31.46 M |
| Income Before Tax Ratio
|
-5.04
|
-4.91
|
-6.59
|
-7
|
-9.08
|
-15.54
|
-15.21
|
-268.73
|
-309.51
|
-257.87
|
| Income Tax Expense |
$850,000.00 |
-$77,000.00 |
$45,000.00 |
$5,000.00 |
-$111,000.00 |
$211,000.00 |
-$651,000.00 |
$267,000.00 |
$74,000.00 |
-$527,000.00 |
| Net Income |
-$61.62 M |
-$62.49 M |
-$77.70 M |
-$78.21 M |
-$84.31 M |
-$88.33 M |
-$62.88 M |
-$66.37 M |
-$45.50 M |
-$30.93 M |
| Net Income Ratio |
-5.11 |
-4.9 |
-6.59 |
-7 |
-9.07 |
-15.58 |
-15.05 |
-269.81 |
-309.51 |
-253.55 |
| EPS |
-4.94 |
-7.61 |
-12.59 |
-13.96 |
-15.47 |
-16.21 |
-11.63 |
-12.94 |
-10.11 |
-7.09 |
| EPS Diluted |
-4.94 |
-7.61 |
-12.59 |
-13.96 |
-15.47 |
-16.21 |
-11.63 |
-12.94 |
-10.11 |
-7.09 |
| Weighted Average Shares
Out |
$12.48 M
|
$8.22 M
|
$6.17 M
|
$5.60 M
|
$5.45 M
|
$5.45 M
|
$5.41 M
|
$5.13 M
|
$4.50 M
|
$4.36 M
|
| Weighted Average Shares
Out Diluted |
$12.48 M
|
$8.22 M
|
$6.17 M
|
$5.60 M
|
$5.45 M
|
$5.45 M
|
$5.41 M
|
$5.13 M
|
$4.50 M
|
$4.36 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
